Cargando…
Risk of Gastrointestinal Bleeding Among Dabigatran Users – A Self Controlled Case Series Analysis
This article aims to evaluate the real world risk of gastrointestinal bleeding among users naïve to dabigatran. We adopted a self-controlled case series design. We sampled 1215 eligible adult participants who were continuous insured users between July 1, 2010 and March 31, 2012 with use of dabigatra...
Autores principales: | Tang, Wenze, Chang, Hsien-Yen, Zhou, Meijia, Singh, Sonal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247708/ https://www.ncbi.nlm.nih.gov/pubmed/28106053 http://dx.doi.org/10.1038/srep40120 |
Ejemplares similares
-
Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study
por: Chang, Hsien-Yen, et al.
Publicado: (2015) -
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
por: Abraham, Neena S, et al.
Publicado: (2015) -
Risk factors and prevention of dabigatran‐related gastrointestinal bleeding in patients with atrial fibrillation
por: Nantsupawat, Teerapat, et al.
Publicado: (2017) -
Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab
por: Riario Sforza, Gian Galeazzo, et al.
Publicado: (2018) -
Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation
por: Zhou, Meijia, et al.
Publicado: (2015)